BeEAM (bendamustine, etoposide, cytarabine, melphalan) before...

We designed a phase 1-2 study to evaluate the safety and the efficacy of increasing doses of bendamustine coupled with fixed doses of etoposide, cytarabine, and melphalan as the conditioning regimen to autologous stem cell transplantation for resistant/relapsed lymphoma patients.

http://www.citeulike.org/user/eisei/article/11753290